Interações de Ramelteona

Ramelteona (Rozerem), sedativo-hipnótico, tem 285 interações documentadas nas bulas da FDA e nas fichas informativas que indexamos (graves: 87; moderadas: 179; leves: 18; casos em que uma bula relata não haver interação significativa: 1). Cada item abaixo cita a frase em que se baseia. Esta página de medicamento é um ponto de partida, não um veredito para a sua situação.

Interações segundo a bula

Interações graves (87)

  • ÁlcoolÁlcoolGrave

    Alcohol: Causes additive psychomotor impairment; should not be used in combination. (bula de Ramelteona, Interações medicamentosas)

  • AlprazolambenzodiazepínicoGrave

    • Effects on Driving and Operating Machinery: Patients receiving • alprazolam XR should be cautioned against operating machinery or driving a motor vehicle, as well as avoiding concomitant use of alcohol and other central nervous system (CNS) depressant drugs. (bula de Alprazolam, Advertências e precauções)

  • Azelastina + fluticasonaanti-histamínicoGrave

    • Avoid concurrent use of alcohol or other central nervous system (CNS) depressants with azelastine hydrochloride and fluticasone propionate nasal spray because further decreased alertness and impairment of CNS performance may occur. (bula de Azelastina + fluticasona, Advertências e precauções)

  • Beladona + ópioopioideGrave

    …AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL EXPOSURE; NEONATAL OPIOD WITHDRAWAL SYNDROME; and RISKS FROM CONCOMITANT USE WITH ALCOHOL, BENZODIAZEPINES OR OTHER CNS DEPRESSANTS Addiction, Abuse, and Misuse Belladonna and opium suppositories expose patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to… (bula de Beladona + ópio, Advertência em caixa preta)

  • BuprenorfinaopioideGrave

    Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Buprenorfina, Advertência em caixa preta)

  • Concomitant use of opioids or a barbiturate with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Butalbital + ácido acetilsalicílico + cafeína + codeína, Advertência em caixa preta)

  • Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Butalbital + paracetamol + cafeína + codeína, Advertência em caixa preta)

  • ButorfanolopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Butorfanol, Advertência em caixa preta)

  • Fluvoxamine (strong CYP1A2 inhibitor): Increases AUC for ramelteon and should not be used in combination. (bula de Ramelteona, Contraindicações)

  • CarbamazepinaanticonvulsivanteGrave

    CNS Depressants The concomitant use of EQUETRO and other CNS depressants can increase the risk of respiratory depression, profound sedation, hypotension, and syncope. (bula de Carbamazepina, Interações medicamentosas)

  • Carbinoxaminaanti-histamínicoGrave

    Avoid concurrent use of Carbinoxamine Maleate Extended-Release Oral Suspension with alcohol or other central nervous system depressants because additional impairment of central nervous system performance may occur. (bula de Carbinoxamina, Advertências e precauções)

  • Cetaminadepressor do SNCGrave

    Benzodiazepines, Opioid Analgesics, or other CNS Depressants : Concomitant use may result in profound sedation, respiratory depression, coma, or death. (bula de Cetamina, Interações medicamentosas)

  • Cetirizinaanti-histamínicoGrave

    Avoid concurrent use of QUZYTTIR with alcohol or other CNS depressants because additional reduction in alertness and additional impairment of CNS performance may occur. (bula de Cetirizina, Advertências e precauções)

  • Cetoconazolantifúngico azólicoGrave

    This may potentiate and prolong hypnotic and sedative effects, especially with repeated dosing or chronic administration of these agents. (bula de Cetoconazol, Contraindicações)

  • Ciclobenzaprinarelaxante muscularGrave

    Based on its structural similarity to TCAs, concomitant use of TONMYA with: MAO inhibitors may be life-threatening [see Contraindications (4) ] , Alcohol, barbiturates, and other CNS depressants may increase the risk of adverse reactions associated with these drugs, Tramadol may increase the seizure risk, Guanethidine or other similar acting drugs may block the… (bula de Ciclobenzaprina, Interações medicamentosas)

  • Cimetidinabloqueador H2Grave

    Fluvoxamine (strong CYP1A2 inhibitor): Increases AUC for ramelteon and should not be used in combination. (bula de Ramelteona, Contraindicações)

  • CiprofloxacinofluoroquinolonaGrave

    Fluvoxamine (strong CYP1A2 inhibitor): Increases AUC for ramelteon and should not be used in combination. (bula de Ramelteona, Contraindicações)

  • ClobazambenzodiazepínicoGrave

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (bula de Clobazam, Advertências e precauções)

  • ClonazepambenzodiazepínicoGrave

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (bula de Clonazepam, Advertências)

  • Clonidinaagonista alfa-adrenérgicoGrave

    Avoid use with other central nervous system (CNS) depressants ( 5.3 ) (bula de Clonidina, Advertências e precauções)

  • ClorazepatobenzodiazepínicoGrave

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (bula de Clorazepato, Advertências)

  • ClordiazepóxidobenzodiazepínicoGrave

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (bula de Clordiazepóxido, Advertências)

  • Clordiazepóxido + clidíniobenzodiazepínicoGrave

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (bula de Clordiazepóxido + clidínio, Advertências)

  • Clorfeniraminaanti-histamínicoGrave

    …have a breathing problem such as emphysema or chronic bronchitis glaucoma trouble urinating due to an enlarged prostate gland Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers When using this product excitability may occur, especially in children drowsiness may occur avoid alcoholic beverages alchohol, sedatives and tranquilizers… (bula de Clorfeniramina, Advertências)

  • ClorpromazinaantipsicóticoGrave

    Do not use in comatose states or in the presence of large amounts of central nervous system depressants (alcohol, barbiturates, narcotics, etc.). (bula de Clorpromazina, Contraindicações)

  • CodeínaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Codeína, Advertência em caixa preta)

  • DarunavirantirretroviralGrave

    …modifying agents: lomitapide, lovastatin, simvastatin Opioid Antagonist: naloxegol PDE-5 inhibitor: sildenafil when used for treatment of pulmonary arterial hypertension Sedatives/hypnotics: orally administered midazolam, triazolam Co-administration of PREZISTA/ritonavir is contraindicated with drugs that are highly dependent on CYP3A for clearance and for which… (bula de Darunavir, Contraindicações)

  • Darunavir + cobicistateantirretroviralGrave

    …modifying agents: lomitapide, lovastatin, simvastatin Opioid Antagonist: naloxegol PDE-5 inhibitor: sildenafil when used for treatment of pulmonary arterial hypertension Sedatives/hypnotics: orally administered midazolam, triazolam PREZCOBIX or PREZCOBIX PED is contraindicated in patients receiving certain co-administered drugs for which altered plasma concentrations… (bula de Darunavir + cobicistate, Contraindicações)

  • Deferasiroxsuplemento de ferroGrave

    Fluvoxamine (strong CYP1A2 inhibitor): Increases AUC for ramelteon and should not be used in combination. (bula de Ramelteona, Contraindicações)

  • DiazepambenzodiazepínicoGrave

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (bula de Diazepam, Advertências)

  • CONTRAINDICATIONS Diphenoxylate hydrochloride and atropine sulfate is contraindicated in: • Pediatric patients less than 6 years of age due to the risks of respiratory and central nervous system (CNS) depression (see WARNINGS ). (bula de Difenoxilato + atropina, Contraindicações)

  • Doxilaminaanti-histamínicoGrave

    …breathing problem such as emphysema or chronic bronchitis • glaucoma • trouble urinating due to an enlarged prostate gland Ask a doctor or pharmacist before use if you are taking • a sedative or any other sleep-aid • tranquilizers • any other antihistamines • any other drugs When using this product • avoid alcoholic beverages • do not drive a motor vehicle or operate… (bula de Doxilamina, Advertências)

  • Doxilamina + piridoxinaanti-histamínicoGrave

    Central nervous system (CNS) depressants: Concurrent use with alcohol or other CNS depressants is not recommended ( 5.1 ) (bula de Doxilamina + piridoxina, Advertências e precauções)

  • …Lipid-modifying Agents: lomitapide, lovastatin, simvastatin Phosphodiesterase-5 (PDE-5) Inhibitor: sildenafil when administered as REVATIO ® for the treatment of pulmonary arterial hypertension Sedative/hypnotics: triazolam, orally administered midazolam Coadministration of GENVOYA is contraindicated with drugs that: Are highly dependent on CYP3A for clearance and for which… (bula de Elvitegravir + cobicistate + entricitabina + tenofovir, Contraindicações)

  • Eszopiclonasedativo-hipnóticoGrave

    The use of LUNESTA with other sedative-hypnotics at bedtime or the middle of the night is not recommended. (bula de Eszopiclona, Advertências e precauções)

  • Fenelzinainibidor da MAOGrave

    Phenelzine sulfate should not be used in combination with dextromethorphan or with CNS depressants such as alcohol and certain narcotics. (bula de Fenelzina, Contraindicações)

  • FenobarbitalbarbitúricoGrave

    CNS depressants: Closely monitor for sedation and respiratory depression. (bula de Fenobarbital, Interações medicamentosas)

  • FentanilaopioideGrave

    • Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Fentanila, Advertência em caixa preta)

  • FlufenazinaantipsicóticoGrave

    CONTRAINDICATIONS Phenothiazines are contraindicated in patients with suspected or established subcortical brain damage, in patients receiving large doses of hypnotics, and in comatose or severely depressed states. (bula de Flufenazina, Contraindicações)

  • FluvoxaminaISRSGrave

    Patients should not take ROZEREM in conjunction with fluvoxamine [see Drug Interactions (7) ] . (bula de Ramelteona, Contraindicações)

  • FosamprenavirantirretroviralGrave

    …Hypericum perforatum ) Lipid modifying agents: Lomitapide, lovastatin, simvastatin Non-nucleoside reverse transcriptase inhibitor: Delavirdine PDE5 inhibitor: Sildenafil (Revatio) (for treatment of pulmonary arterial hypertension) Sedative/hypnotics: Midazolam, triazolam Hypersensitivity to fosamprenavir calcium or amprenavir (e.g., Stevens-Johnson syndrome). (bula de Fosamprenavir, Contraindicações)

  • GabapentinaanticonvulsivanteGrave

    • Respiratory Depression: May occur with NEURONTIN when used with concomitant central nervous system (CNS) depressants, including opioids, or in the setting of underlying respiratory impairment. (bula de Gabapentina, Advertências e precauções)

  • HidrocodonaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Hidrocodona, Advertência em caixa preta)

  • …ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; MEDICATION ERRORS; CYTOCHROME P450 3A4 INTERACTION; CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; INTERACTION WITH ALCOHOL; NEONATAL OPIOID WITHDRAWAL SYNDROME WARNING: ADDICTION, ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION;… (bula de Hidrocodona + clorfeniramina, Advertência em caixa preta)

  • …ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; MEDICATION ERRORS; CYTOCHROME P450 3A4 INTERACTION; CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; INTERACTION WITH ALCOHOL; NEONATAL OPIOID WITHDRAWAL SYNDROME Addiction, Abuse, and Misuse Hydrocodone bitartrate and homatropine methylbromide exposes patients and… (bula de Hidrocodona + homatropina, Advertência em caixa preta)

  • …LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; CYTOCHROME P4503A4 INTERACTION; RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; and SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF HYDROCODONE BITARTRATE AND IBUPROFEN TABLETS Addiction,… (bula de Hidrocodona + ibuprofeno, Advertência em caixa preta)

  • Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Hidrocodona + paracetamol, Advertência em caixa preta)

  • HidromorfonaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death . (bula de Hidromorfona, Advertência em caixa preta)

  • Hidroxizinaanti-histamínicoGrave

    Rarely, cardiac arrests and death have been reported in association with the combined use of hydroxyzine hydrochloride intramuscularly and other CNS depressants. (bula de Hidroxizina, Precauções)

  • Levocetirizinaanti-histamínicoGrave

    Avoid concurrent use of alcohol or other central nervous system depressants with XYZAL. (bula de Levocetirizina, Advertências e precauções)

  • LevorfanolopioideGrave

    Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Levorfanol, Advertência em caixa preta)

  • Lopinavir + ritonavirantirretroviralGrave

    …Non-opioid Analgesic (selective blocker of Nav1.8 sodium channels): suzetrigine PDE5 Inhibitor: sildenafil (Revatio ® ) when used for the treatment of pulmonary arterial hypertension Sedative/Hypnotics: triazolam, orally administered midazolam KALETRA is contraindicated with drugs that are potent CYP3A inducers where significantly reduced lopinavir plasma concentrations… (bula de Lopinavir + ritonavir, Contraindicações)

  • LorazepambenzodiazepínicoGrave

    Caution patients receiving LOREEV XR against operating machinery or driving a motor vehicle as well to avoid the concomitant use of alcohol and other CNS depressant drugs during treatment ( 5.4 , 7 ) (bula de Lorazepam, Advertências e precauções)

  • MetadonaopioideGrave

    Managing Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, is a risk factor for respiratory depression and death [see Warnings and Precautions ( 5.2 )]. (bula de Metadona, Advertência em caixa preta)

  • Metaxalonarelaxante muscularGrave

    If concomitant use with another CNS depressant is warranted, closely monitor for signs of respiratory depression and sedation, particularly during treatment initiation and dosage increases. (bula de Metaxalona, Advertências e precauções)

  • MexiletinaantiarrítmicoGrave

    Fluvoxamine (strong CYP1A2 inhibitor): Increases AUC for ramelteon and should not be used in combination. (bula de Ramelteona, Contraindicações)

  • MidazolambenzodiazepínicoGrave

    WARNING: PERSONNEL AND EQUIPMENT FOR MONITORING AND RESUSCITATION AND RISKS FROM CONCOMITANT USE WITH OPIOID ANALGESICS AND OTHER SEDATIVE-HYPNOTICS Personnel and Equipment for Monitoring and Resuscitation Only personnel trained in the administration of procedural sedation, and not involved in the conduct of the diagnostic or therapeutic procedure, should administer… (bula de Midazolam, Advertência em caixa preta)

  • MorfinaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Morfina, Advertência em caixa preta)

  • NalbufinaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Nalbufina, Advertência em caixa preta)

  • Nalmefenoantagonista opioideGrave

    Risk of Recurrent Respiratory and CNS Depression : A recurrence of respiratory depression is possible, therefore, keep the patient under continued surveillance and administer repeat doses of ZURNAI using a new auto-injector with each dose while awaiting emergency medical assistance. (bula de Nalmefeno, Advertências e precauções)

  • …(selective blocker of Na v 1.8 sodium channels): suzetrigine • Opioid antagonists: naloxegol • PDE5 inhibitor: sildenafil (Revatio ® ) when used for pulmonary arterial hypertension (PAH) • Sedative/hypnotics: triazolam, oral midazolam • Serotonin receptor 1A agonist/serotonin receptor 2A antagonist: flibanserin • Vasopressin receptor antagonists: tolvaptan ➢ Drugs that… (bula de Nirmatrelvir + ritonavir, Contraindicações)

  • OliceridinaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Oliceridina, Advertência em caixa preta)

  • Olopatadinaanti-histamínicoGrave

    • Avoid concurrent use of alcohol or other central nervous system depressants with olopatadine hydrochloride nasal solution (nasal spray) ( 5.2 ). (bula de Olopatadina, Advertências e precauções)

  • Olopatadina + mometasonaanti-histamínicoGrave

    • Avoid concurrent use of alcohol or other central nervous system (CNS) depressants with RYALTRIS because additional reductions in alertness and additional impairment of CNS performance may occur. (bula de Olopatadina + mometasona, Advertências e precauções)

  • OxazepambenzodiazepínicoGrave

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (bula de Oxazepam, Advertências)

  • Oxibato de sódiodepressor do SNCGrave

    • Central Nervous System Depression Xyrem (sodium oxybate) is a CNS depressant. (bula de Oxibato de sódio, Advertência em caixa preta)

  • OxicodonaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Oxicodona, Advertência em caixa preta)

  • …LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; CYTOCHROME P450 3A4 INTERACTION; and RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS Addiction, Abuse, and Misuse Oxycodone hydrochloride tablets exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to… (bula de Oxicodona + paracetamol, Advertência em caixa preta)

  • OximorfonaopioideGrave

    Risks From Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Oximorfona, Advertência em caixa preta)

  • Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Paracetamol + codeína, Advertência em caixa preta)

  • …MITIGATION STRATEGY (REMS); LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; and RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS Addiction, Abuse, and Misuse Pentazocine and Naloxone Tablets exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to… (bula de Pentazocina + naloxona, Advertência em caixa preta)

  • PerfenazinaantipsicóticoGrave

    CONTRAINDICATIONS Perphenazine products are contraindicated in comatose or greatly obtunded patients and in patients receiving large doses of central nervous system depressants (barbiturates, alcohol, narcotics, analgesics, or antihistamines); in the presence of existing blood dyscrasias, bone marrow depression, or liver damage; and in patients who have shown… (bula de Perfenazina, Contraindicações)

  • Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Petidina (meperidina), Advertência em caixa preta)

  • PregabalinaanticonvulsivanteGrave

    • Respiratory Depression : May occur with LYRICA when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. (bula de Pregabalina, Advertências e precauções)

  • ProclorperazinaantipsicóticoGrave

    Do not use in comatose states or in the presence of large amounts of central nervous system depressants (alcohol, barbiturates, narcotics, etc.). Do not use in pediatric surgery. (bula de Proclorperazina, Contraindicações)

  • …PROMETHAZINE AND RESPIRATORY DEPRESSION IN CHILDREN; MEDICATION ERRORS; INTERACTIONS WITH DRUGS AFFECTING CYTOCHROME P450 ISOENZYMES; CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; NEONATAL OPIOID WITHDRAWAL SYNDROME Addiction, Abuse, and Misuse Promethazine HCl and Codeine Phosphate Oral Solution exposes patients and other users to the risks… (bula de Prometazina + codeína, Advertência em caixa preta)

  • RemifentanilaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Remifentanila, Advertência em caixa preta)

  • RitonavirantirretroviralGrave

    WARNING: DRUG-DRUG INTERACTIONS LEADING TO POTENTIALLY SERIOUS AND/OR LIFE THREATENING REACTIONS Co-administration of NORVIR with several classes of drugs including sedative hypnotics, antiarrhythmics, or ergot alkaloid preparations may result in potentially serious and/or life-threatening adverse events due to possible effects of NORVIR on the hepatic metabolism… (bula de Ritonavir, Advertência em caixa preta)

  • TapentadolopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Tapentadol, Advertência em caixa preta)

  • TramadolopioideGrave

    Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Tramadol, Advertência em caixa preta)

  • Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Tramadol + paracetamol, Advertência em caixa preta)

  • TriazolambenzodiazepínicoGrave

    • Effects on Driving and Operating Heavy Machinery : Patients receiving triazolam should be cautioned against driving or operating heavy machinery, as well as avoiding concomitant use with alcohol and other CNS depressant drugs. (bula de Triazolam, Advertências e precauções)

  • TrifluoperazinaantipsicóticoGrave

    CONTRAINDICATIONS A known hypersensitivity to phenothiazines, comatose or greatly depressed states due to central nervous system depressants and, in cases of existing blood dyscrasias, bone marrow depression and preexisting liver damage. (bula de Trifluoperazina, Contraindicações)

  • Viloxazinainibidor da recaptação de noradrenalinaGrave

    Fluvoxamine (strong CYP1A2 inhibitor): Increases AUC for ramelteon and should not be used in combination. (bula de Ramelteona, Contraindicações)

  • Zaleplonasedativo-hipnóticoGrave

    The use of zaleplon with other sedative-hypnotics at bedtime or the middle of the night is not recommended (see ). (bula de Zaleplona, Advertências)

  • Zileutonainibidor da CYP1A2Grave

    Fluvoxamine (strong CYP1A2 inhibitor): Increases AUC for ramelteon and should not be used in combination. (bula de Ramelteona, Contraindicações)

  • Zolpidemsedativo-hipnóticoGrave

    The use of Zolpidem Tartrate with other sedative-hypnotics (including other zolpidem products) at bedtime or the middle of the night is not recommended. (bula de Zolpidem, Advertências e precauções)

Interações moderadas (179)

  • Ácido valproicoanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Alopurinolinibidor da xantina oxidaseModerada

    Inform patients also that the central nervous system depressant effects of allopurinol tablets may be additive to those of alcohol and other CNS depressants. (bula de Alopurinol, Advertências e precauções)

  • AminofilinametilxantinaModerada

    25% increase Diazepam Benzodiazepines increase CNS concentrations of adenosine, a potent CNS depressant, while theophylline blocks adenosine receptors. (bula de Aminofilina, Interações medicamentosas)

  • AmiodaronaantiarrítmicoModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Amitriptilinaantidepressivo tricíclicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Amoxapinaantidepressivo tricíclicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Aprepitantoinibidor da CYP3A4Moderada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • AripiprazolantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Armodafinilaestimulante do SNCModerada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • AsenapinaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • AtazanavirantirretroviralModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Azelastinaanti-histamínicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Baclofenorelaxante muscularModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • BicalutamidaandrogênioModerada

    Reproductive effects: Include decreased testosterone and increased prolactin levels. (bula de Ramelteona, Advertências e precauções)

  • Sedatives/Hypnotics: midazolam (oral) triazolam ↑ midazolam (oral) ↑ triazolam Use caution when midazolam or triazolam is concomitantly administered with BIXLENVO. (bula de Bictegravir + entricitabina + tenofovir alafenamida, Interações medicamentosas)

  • Bosentanaindutor da CYP3A4Moderada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • BrexpiprazolantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Brimonidinaagonista alfa-adrenérgicoModerada

    Use with CNS depressants may result in an additive or potentiating effect. (bula de Brimonidina, Interações medicamentosas)

  • Brimonidina + timololagonista alfa-adrenérgicoModerada

    Use with CNS depressants may result in an additive or potentiating effect. (bula de Brimonidina + timolol, Interações medicamentosas)

  • BrivaracetamanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Bupivacaínaanestésico localModerada

    Possible early warning signs of central nervous system (CNS) toxicity are restlessness, anxiety, incoherent speech, lightheadedness, numbness and tingling of the mouth and lips, metallic taste, tinnitus, dizziness, blurred vision, tremors, twitching, CNS depression, or drowsiness. (bula de Bupivacaína, Advertências e precauções)

  • Bupivacaína + epinefrinaanestésico localModerada

    Possible early warning signs of central nervous system (CNS) toxicity are restlessness, anxiety, incoherent speech, lightheadedness, numbness and tingling of the mouth and lips, metallic taste, tinnitus, dizziness, blurred vision, tremors, twitching, CNS depression, or drowsiness. (bula de Bupivacaína + epinefrina, Advertências e precauções)

  • The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Buspironamedicamento serotoninérgicoModerada

    Triazolam/flurazepam: Coadministration of buspirone with either triazolam or flurazepam did not appear to prolong or intensify the sedative effects of either benzodiazepine. (bula de Buspirona, Interações medicamentosas)

  • The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Butalbital + paracetamolbarbitúricoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • CapecitabinaantimetabólitoModerada

    Fluconazole (strong CYP2C9 inhibitor): Increases systemic exposure of ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • CariprazinaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Carisoprodolrelaxante muscularModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • CenobamatoanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • CiclosporinaimunossupressorModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Ciproeptadinaanti-histamínicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Claritromicinaantibiótico macrolídeoModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Clemastinaanti-histamínicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Clomipraminaantidepressivo tricíclicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Clorzoxazonarelaxante muscularModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • ClozapinaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • DanazolandrogênioModerada

    Reproductive effects: Include decreased testosterone and increased prolactin levels. (bula de Ramelteona, Advertências e precauções)

  • Dantrolenorelaxante muscularModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Daridorexantosedativo-hipnóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Desfluranoanestésico geralModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Desipraminaantidepressivo tricíclicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Deutetrabenazinainibidor do VMAT2Moderada

    Alcohol or other sedating drugs: May have additive sedation and somnolence ( 7.5 ) (bula de Deutetrabenazina, Interações medicamentosas)

  • DexametasonacorticosteroideModerada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • Dexclorfeniraminaanti-histamínicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Dexmedetomidinaagonista alfa-adrenérgicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Difenidraminaanti-histamínicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Diltiazembloqueador dos canais de cálcioModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Dimenidrinatoanti-histamínicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Dissulfiraminibidor da CYP2C9Moderada

    Fluconazole (strong CYP2C9 inhibitor): Increases systemic exposure of ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Divalproato de sódio (valproato)anticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Donepezilainibidor da colinesteraseModerada

    Donepezil: Increases systemic exposure of ramelteon; patients should be closely monitored when ramelteon is coadministered with donepezil. (bula de Ramelteona, Interações medicamentosas)

  • Doxepinaantidepressivo tricíclicoModerada

    Doxepin: Increases systemic exposure of ramelteon; patients should be closely monitored when ramelteon is coadministered with doxepin. (bula de Ramelteona, Interações medicamentosas)

  • DronabinolcanabinoideModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • DronedaronaantiarrítmicoModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Droperidolantagonista da dopaminaModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • EfavirenzantirretroviralModerada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • Efavirenz + lamivudina + tenofovirantirretroviralModerada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • EluxadolinaopioideModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Eritromicinaantibiótico macrolídeoModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • EscopolaminaanticolinérgicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • EslicarbazepinaanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • EstazolambenzodiazepínicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Reproductive effects: Include decreased testosterone and increased prolactin levels. (bula de Ramelteona, Advertências e precauções)

  • Etomidatoanestésico geralModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • EtossuximidaanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • EtravirinaantirretroviralModerada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • EverolimoimunossupressorModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • FelbamatoanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • FenitoínaanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Fentermina + topiramatoestimulante do SNCModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Flibanserinadepressor do SNCModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Fluconazolantifúngico azólicoModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • FlumazenilbenzodiazepínicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • FluoruracilaantimetabólitoModerada

    Fluconazole (strong CYP2C9 inhibitor): Increases systemic exposure of ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • FlutamidaandrogênioModerada

    Reproductive effects: Include decreased testosterone and increased prolactin levels. (bula de Ramelteona, Advertências e precauções)

  • FluvastatinaestatinaModerada

    Fluconazole (strong CYP2C9 inhibitor): Increases systemic exposure of ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Fosaprepitantoinibidor da CYP3A4Moderada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • FosfenitoínaanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • GriseofulvinaantifúngicoModerada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • Guanfacinaagonista alfa-adrenérgicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • HaloperidolantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • IloperidonaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Imatinibeinibidor da CYP3A4Moderada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Imipraminaantidepressivo tricíclicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Isofluranoanestésico geralModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • IsoniazidaantibióticoModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Itraconazolantifúngico azólicoModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Ivacaftorinibidor da CYP3A4Moderada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • LacosamidaanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Lemborexantosedativo-hipnóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • LenacapavirantirretroviralModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • LevetiracetamanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Lidocaína + epinefrinaanestésico localModerada

    Possible early warning signs of central nervous system (CNS) toxicity are restlessness, anxiety, incoherent speech, lightheadedness, metallic taste, tinnitus, dizziness, blurred vision, tremors, twitching, CNS depression, or drowsiness. (bula de Lidocaína + epinefrina, Advertências e precauções)

  • Lofexidinaagonista alfa-adrenérgicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Lorlatinibeindutor da CYP3A4Moderada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • LoxapinaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • LumateperonaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • LurasidonaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Meclizinaanti-histamínicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Memantina + donepezilainibidor da colinesteraseModerada

    Donepezil: Increases systemic exposure of ramelteon; patients should be closely monitored when ramelteon is coadministered with donepezil. (bula de Ramelteona, Interações medicamentosas)

  • Meprobamatodepressor do SNCModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Mesuximida (metossuximida)anticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • MetiltestosteronaandrogênioModerada

    Reproductive effects: Include decreased testosterone and increased prolactin levels. (bula de Ramelteona, Advertências e precauções)

  • MetirosinaModerada

    Concurrent use of metyrosine with alcohol or other CNS depressants can increase their sedative effects. (bula de Metirosina, Interações medicamentosas)

  • Metocarbamolrelaxante muscularModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Metoclopramidaantagonista da dopaminaModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • MetoexitalbarbitúricoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • MetronidazolantibióticoModerada

    Fluconazole (strong CYP2C9 inhibitor): Increases systemic exposure of ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Miconazolantifúngico azólicoModerada

    Fluconazole (strong CYP2C9 inhibitor): Increases systemic exposure of ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Mifepristonainibidor da CYP3A4Moderada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Mirabegronaagonista beta-adrenérgicoModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • MirtazapinaantidepressivoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Mitapivateindutor da CYP3A4Moderada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • Mitotanoindutor da CYP3A4Moderada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • Modafinilaestimulante do SNCModerada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • Nafcilinaantibiótico da classe das penicilinasModerada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • Naloxonaantagonista opioideModerada

    WARNINGS AND PRECAUTIONS Risk of Recurrent Respiratory and CNS Depression : Due to the duration of action of naloxone relative to the opioid, respiratory and CNS depression may recur after the first dose of naloxone. (bula de Naloxona, Advertências e precauções)

  • Naltrexona + bupropionaantagonista opioideModerada

    …malformation, central nervous system tumor or infection, or metabolic disorders (e.g., hypoglycemia, hyponatremia, severe hepatic impairment, and hypoxia) excessive use of alcohol or sedatives, addiction to cocaine or stimulants, or withdrawal from sedatives patients with diabetes treated with insulin and/or oral diabetic medications (sulfonylureas and meglitinides)… (bula de Naltrexona + bupropiona, Advertências e precauções)

  • NefazodonaantidepressivoModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • NevirapinaantirretroviralModerada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • Nitisinonainibidor da CYP2C9Moderada

    Fluconazole (strong CYP2C9 inhibitor): Increases systemic exposure of ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Nortriptilinaantidepressivo tricíclicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • OlanzapinaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Olanzapina + fluoxetinaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Orfenadrinarelaxante muscularModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • OxcarbazepinaanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Palbociclibeinibidor da CYP3A4Moderada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • PaliperidonaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • PerampanelanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • PimavanserinaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • PimozidaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Posaconazolantifúngico azólicoModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Pramipexolagonista da dopaminaModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • PrimidonaanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Prometazinaanti-histamínicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Prometazina + dextrometorfanoanti-histamínicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Propofoldepressor do SNCModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Protriptilinaantidepressivo tricíclicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • QuetiapinaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Ranolazinamedicamento que prolonga o intervalo QTModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • RifabutinaantibióticoModerada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • RifampicinaantibióticoModerada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • RifapentinaantibióticoModerada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • RisperidonaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Ropinirolagonista da dopaminaModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • RufinamidaanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Sevofluranoanestésico geralModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Fluconazole (strong CYP2C9 inhibitor): Increases systemic exposure of ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Fluconazole (strong CYP2C9 inhibitor): Increases systemic exposure of ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Suvorexantosedativo-hipnóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Suzetriginaindutor da CYP3A4Moderada

    Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon. (bula de Ramelteona, Interações medicamentosas)

  • Tasimelteonasedativo-hipnóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • TemazepambenzodiazepínicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • TeofilinametilxantinaModerada

    25% increase Diazepam Benzodiazepines increase CNS concentrations of adenosine, a potent CNS depressant, while theophylline blocks adenosine receptors. (bula de Teofilina, Interações medicamentosas)

  • TestosteronaandrogênioModerada

    Reproductive effects: Include decreased testosterone and increased prolactin levels. (bula de Ramelteona, Advertências e precauções)

  • Tetrabenazinainibidor do VMAT2Moderada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • TiagabinaanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Ticagrelorantiagregante plaquetárioModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • TioridazinaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • TiotixenoantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Tizanidinarelaxante muscularModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • TopiramatoanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Tranilciprominainibidor da MAOModerada

    Excessive reduction of blood glucose (additive effect) f CNS depressant agents (including opioids, alcohol, sedatives, hypnotics) Use with caution d Increased CNS depression Dietary supplements containing sympathomimetics Contraindicated a Antidepressants including but not limited to: Other MAOIs (e.g., linezolid, intravenous methylene blue, selective MAOIs)… (bula de Tranilcipromina, Interações medicamentosas)

  • TrazodonaantidepressivoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • TriexifenidilanticolinérgicoModerada

    Concurrent use of alcohol or other CNS depressants with trihexyphenidyl may cause increased sedative effects. (bula de Triexifenidil, Interações medicamentosas)

  • The recent use of other drugs that cause CNS depression or EPS symptoms may also increase the risk; consider reducing the dosage or discontinuing the drug. (bula de Trimetobenzamida, Advertências e precauções)

  • TrimetoprimaantibióticoModerada

    Fluconazole (strong CYP2C9 inhibitor): Increases systemic exposure of ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Trimipraminaantidepressivo tricíclicoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Verapamilbloqueador dos canais de cálcioModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • VigabatrinaanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • Voriconazolantifúngico azólicoModerada

    Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • Zafirlucasteantagonista do receptor de leucotrienosModerada

    Fluconazole (strong CYP2C9 inhibitor): Increases systemic exposure of ramelteon; administer with caution. (bula de Ramelteona, Interações medicamentosas)

  • ZiprasidonaantipsicóticoModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

  • ZonisamidaanticonvulsivanteModerada

    The use of alcohol and other CNS depressants may increase the risk of such behaviors. (bula de Ramelteona, Advertências e precauções)

Menções leves (18)

  • The “gasping syndrome” is characterized by central nervous system (CNS) depression, metabolic acidosis, and gasping respirations. (bula de Alfaepoetina, Advertências e precauções)

  • Anfepramona (dietilpropiona)estimulante do SNCLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • Anfetaminaestimulante do SNCLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • Anfetamina + dextroanfetaminaestimulante do SNCLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • Benzfetaminaestimulante do SNCLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • BupropionaantidepressivoLeve

    Additional predisposing conditions include diabetes mellitus treated with oral hypoglycemic drugs or insulin, use of anorectic drugs, excessive use of alcohol, use of benzodiazepines, sedatives/hypnotics, or opiates. (bula de Bupropiona, Advertências e precauções)

  • Cocaínaanestésico localLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • Dexmetilfenidatoestimulante do SNCLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • Dextroanfetaminaestimulante do SNCLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • In Drug-Induced CNS and Respiratory Depression Doxapram alone may not stimulate adequate spontaneous breathing or provide sufficient arousal in patients who are severely depressed either due to respiratory failure or to CNS depressant drugs, but may be used as an adjunct to established supportive measures and resuscitative techniques. (bula de Doxapram, Advertências)

  • Ergotamina + cafeínaalcaloide do ergotLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • Fendimetrazinaestimulante do SNCLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • Fenterminaestimulante do SNCLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • Lisdexanfetaminaestimulante do SNCLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • Metanfetaminaestimulante do SNCLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • Metilfenidatoestimulante do SNCLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

  • PrazosinaalfabloqueadorLeve

    …to date with the following: (1) cardiac glycosides– digitalis and digoxin; (2) hypoglycemics–insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide; (3) tranquilizers and sedatives–chlordiazepoxide, diazepam, and phenobarbital; (4) antigout–allopurinol, colchicine, and probenecid; (5) antiarrhythmics–procainamide, propranolol (see WARNINGS however),… (bula de Prazosina, Interações medicamentosas)

  • Solriamfetolestimulante do SNCLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (bula de Ramelteona, Advertências e precauções)

Nenhuma interação significativa relatada (1)

  • Montelucasteantagonista do receptor de leucotrienosSem interação

    …adjustment is needed when SINGULAIR is co-administered with theophylline, prednisone, prednisolone, oral contraceptives, fexofenadine, digoxin, warfarin, gemfibrozil, itraconazole, thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines, decongestants, and Cytochrome P450 (CYP) enzyme inducers [see Clinical Pharmacology (12.3) ]. (bula de Montelucaste, Interações medicamentosas)

Verifique Ramelteona com tudo o que você toma. Adicione sua lista completa; todos os pares são verificados de uma vez.

Abrir no verificador

Não é aconselhamento médico. A gravidade reflete a redação da bula, não as suas circunstâncias. Um alerta “grave” pode ser rotina sob supervisão, e um “leve” pode ser importante em doses altas. Pergunte a um farmacêutico.